期刊文献+

蛋白质组学技术在眼底病研究中的应用进展 被引量:1

Research progress of proteomics technology in fundus diseases
原文传递
导出
摘要 蛋白质组学是根据时间、空间及细胞类型定性、定量地研究一个蛋白质组的所有蛋白,包括蛋白质表达、细胞定位、蛋白质问相互作用、翻译后修饰及蛋白质周转。蛋白质组学的常用技术包括蛋白质分离、鉴定技术及生物信息学分析。蛋白质组学在眼底病研究中主要用于筛选玻璃体液及血浆中的特征性蛋白,开发特异的生物学标志物;探索差异性蛋白可能参与的发病机制,如视网膜变性、视网膜血管通透性的改变等,为疾病的早期诊断及治疗方案的优化提供帮助。目前蛋白组学技术应用于探索老年性黄斑变性、特发性黄斑前膜、糖尿病视网膜病变、增生性玻璃体视网膜病变、视网膜色素变性等眼底病的发病机制、诊断、治疗等方面。 Proteomic is committed to study a proteome according to the time, space and cell types qualitatively and quantitatively, including protein expression and cellular localization, the protein-protein in- teraction, and protein modification after translation and protein turnover. The general research techniques used in proteomics include protein separation techniques and identification technology and bioinformatics a- nalysis. The application of proteomics in fundus diseases research mainly include to screen typical proteins in vitreous and plasma, to explore the pathogenesis which different proteins may be involved, such as retinal degeneration and changes of retinal vascular permeability, and to optimize the treatment plan. Now the pro- teomic technology is used to explore the pathogenesis, diagnosis and treatment of age-related macular degeneration, idiopathic macular membrane, diabetic retinopathy, proliferative vitreoretinopathy, retinitis pigmen- tosa and so on.
作者 丁楠楠 于蒙溪 武志峰 DING Nan-nan YU Meng-xi WU Zhi-feng.(Department of Ophthalmology, Wuxi No. 2 Hospital Affiliated to Nanjing Medical University, Wuxi 214002, China)
出处 《国际眼科纵览》 2017年第1期52-55,共4页 International Review of Ophthalmology
关键词 蛋白组学 眼底病 质谱法 proteomics fundus diseases mass spectrometry
  • 相关文献

参考文献2

二级参考文献28

  • 1朱忠桥,王丽丽,刘蓓,王勇.氟尿嘧啶联合低分子肝素预防增殖性玻璃体视网膜病变的临床观察[J].第四军医大学学报,2006,27(15):1421-1424. 被引量:1
  • 2Hochstrasser DF, Sanchez JC, Appel RD. Proteomies and its trends facing nature's complexity. Proteomics, 2002, 2:807-812.
  • 3Shitama T, Hayashi H, Noge S, et al. Proteome profiling of vitreoretinal diseases by cluster analysis. Proteomics Clin Appl, 2008, 2:1265-1280.
  • 4Charteris DG, Sethi CS, Lewis GP, et al. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology. Eye, 2002, 16:369-374.
  • 5Broekhuyse RM, Rademakers AJ, Van Vugt AH, et al. Autoimmune responsiveness to retinal IRBP, S-antigen and opsin in proliferative vitreoretinopathy. Exp Eye Res, 1990, 50:197-202.
  • 6Baudouin C, Fredj-Reygrobellet D, Gordon WC, et al. Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy. Am J Ophthalmol, 1990, 110:593-598.
  • 7Kociok N, Joussen AM. Enhanced expression of the complement factor H mRNA in proliferating human RPE cells. Graefes Arch Clin Exp Ophthalmol, 2010, 248 : 1145-1153.
  • 8Hu J, Bok D. Culture of highly differentiated human retinal pigment epithelium for analysis of the polarized uptake, processing, and secretion of retinoids. Methods Mol Biol, 2010, 652:55-73.
  • 9Lovell MA, Lynn BC, Xiong S, et al. An aberrant protein complex in CSF as a biomarker of Alzheimer disease. Neurology, 2008, 70:2212-2218.
  • 10Westermark GT, Westermark P. Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes. Exp Diabetes Res, 2008, 2008:429274.

共引文献10

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部